Ilmarinen Mutual Pension Insurance Co raised its position in Danaher Corporation (NYSE:DHR – Free Report) by 9.2% during the third quarter, Holdings Channel reports. The fund owned 108,700 shares of the conglomerate’s stock after acquiring an additional 9,200 shares during the period. Ilmarinen Mutual Pension Insurance Co’s holdings in Danaher were worth $24,082,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. grew its position in Danaher by 24.6% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 2,658 shares of the conglomerate’s stock valued at $589,000 after buying an additional 524 shares during the period. Sumitomo Life Insurance Co. increased its holdings in Danaher by 1.2% during the third quarter. Sumitomo Life Insurance Co. now owns 6,670 shares of the conglomerate’s stock valued at $1,478,000 after buying an additional 80 shares during the last quarter. Whittier Trust Co. increased its holdings in Danaher by 0.8% during the third quarter. Whittier Trust Co. now owns 398,812 shares of the conglomerate’s stock valued at $87,663,000 after buying an additional 3,327 shares during the last quarter. TIAA Trust National Association raised its position in Danaher by 81.0% in the third quarter. TIAA Trust National Association now owns 391 shares of the conglomerate’s stock worth $87,000 after acquiring an additional 175 shares during the period. Finally, Advisors Asset Management Inc. bought a new position in Danaher in the third quarter worth approximately $1,348,000. Institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of NYSE:DHR opened at $220.42 on Friday. The company has a market capitalization of $155.07 billion, a P/E ratio of 36.08, a P/E/G ratio of 2.89 and a beta of 0.76. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm’s 50 day simple moving average is $224.82 and its two-hundred day simple moving average is $201.66. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.89 earnings per share. Research analysts expect that Danaher Corporation will post 8.59 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.
Insiders Place Their Bets
In other news, CAO Christopher Bouda sold 7,598 shares of the business’s stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Gregory M. Milosevich sold 2,100 shares of the stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the sale, the executive vice president owned 22,367 shares of the company’s stock, valued at $5,158,277.54. This represents a 8.58% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 10.80% of the company’s stock.
Analyst Upgrades and Downgrades
DHR has been the topic of several analyst reports. TD Cowen lifted their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, October 22nd. Barclays upped their price objective on Danaher from $255.00 to $260.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $275.00 target price on shares of Danaher in a report on Thursday, October 22nd. JPMorgan Chase & Co. lifted their target price on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Finally, Citigroup lifted their target price on Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $242.91.
Check Out Our Latest Analysis on Danaher
About Danaher
Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.
Featured Stories
- Five stocks we like better than Danaher
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
